Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis — Valuation, Growth & Financial Health

Five-Pillar Analysis for RARE

TopTier Strategy breaks every stock down into five clear pillars — so you can quickly see what makes Ultragenyx Pharmaceutical Inc. a strong or weak investment candidate.

▲ Valuation

Is RARE priced fairly?

P/E, EV/EBITDA, P/B, and free cash flow yield — versus sector medians and RARE's own history. Our valuation engine flags whether Ultragenyx Pharmaceutical Inc. is trading rich, fair, or cheap.

▲ Profitability

How efficient is Ultragenyx Pharmaceutical Inc.?

Gross margin, operating margin, net margin — and how they're trending. Stable or expanding margins signal pricing power; declining margins are an early warning.

▲ Financial Health

Can RARE survive a downturn?

Debt-to-equity, current ratio, quick ratio, and interest coverage. We screen Ultragenyx Pharmaceutical Inc.'s balance sheet for stress and flag liquidity or leverage risk.

▲ Returns

What's RARE earning on capital?

Return on Equity, Return on Invested Capital, and Return on Assets. We compare Ultragenyx Pharmaceutical Inc.'s capital efficiency to peers — and check leverage to make sure ROE isn't financial-engineering noise.

▲ Growth

Is Ultragenyx Pharmaceutical Inc. expanding?

Revenue growth, EPS growth, and free cash flow growth — over 1, 3, and 5 years. We separate genuine operating growth from buyback-driven EPS gains.

→ Get the Full Picture

See the complete RARE breakdown

Sign up free to unlock Ultragenyx Pharmaceutical Inc.'s full five-pillar analysis with live financial data, peer comparisons, and historical context.

Sign up free →

Frequently Asked Questions about RARE

Quick answers to the most common questions about Ultragenyx Pharmaceutical Inc..

What does Ultragenyx Pharmaceutical Inc. (RARE) do?

Ultragenyx Pharmaceutical Inc. is a publicly traded company under the ticker symbol RARE. Sign up to TopTier Strategy to view a full business overview — including segments, competitive position, and how revenue is generated.

How do I analyze RARE stock?

The five-pillar framework — Valuation, Profitability, Financial Health, Returns, and Growth — is the cleanest way to evaluate any stock, including RARE. Each pillar uses standardized metrics that let you compare Ultragenyx Pharmaceutical Inc. to its peers and to its own history.

Is RARE a good stock to buy?

Whether Ultragenyx Pharmaceutical Inc. fits your portfolio depends on your time horizon, risk tolerance, and investing style. TopTier Strategy gives you the structured data — valuation, profitability, balance sheet health, returns on capital, and growth — to make that decision with conviction.

Where can I see RARE's financial data?

Sign up free at TopTier Strategy to access Ultragenyx Pharmaceutical Inc.'s complete financial profile, including historical metrics, peer comparisons, and our five-pillar score breakdown.

Popular Stocks

Other widely-followed stocks investors research on TopTier Strategy.

Ultragenyx Pharmaceutical Inc. (RARE)